Back to Journals » Open Access Rheumatology: Research and Reviews » Volume 3

Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: patient and cost-effectiveness considerations

Total article views   HTML views PDF downloads Totals
13,308 Dovepress* 11,075+ 4,554 15,629
PubMed Central* 2,233 124 2,357
Totals 13,308 4,678 17,986
*Since 4 August 2011
+Since July 2016

View citations on PubMed Central and Google Scholar